Federal contract award
75N92E23F00002
SINGLE CELL RNA SEQUENCING EXPERIMENTS AND ASSAYS FOR TRANSPOSASE-ACCESSIBLE CHROMATIN WITH SEQUENCING (ATAC-SEQ). [23-001077]
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NHGRI |
| NAICS | 325413 — In-Vitro Diagnostic Substance Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | 75N98022A00032 |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $13.1K |
| Current contract value | $13.1K |
| Potential contract value / ceiling | $13.1K |
| Start date | Apr 13, 2022 |
| Current end date | Mar 31, 2023 |
| Potential end date | Mar 31, 2023 |
| Latest award activity | Dec 7, 2022 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Dec 7, 2022 | 0 | $13.1K | SINGLE CELL RNA SEQUENCING EXPERIMENTS AND ASSAYS FOR TRANSPOSASE-ACCESSIBLE CHROMATIN WITH SEQUENCING (ATAC-SEQ). [23-001077] |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.